In Mdr2−/− mice (a primary sclerosing cholangitis (PSC) model), inhibition of SCF by Vivo-Morpholino treatment reduced MC migration, biliary proliferation/and senescence, stellate cell activation, and liver fibrosis (Meadows et al., 2019). This evidence concerns the gene KITLG and Hepatic fibrosis.